Basics Instil Bio, Inc. IPO Date: March 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $194.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.64 | 4.27% Avg Daily Range (30 D): $1.78 | 8.82% Avg Daily Range (90 D): $1.35 | 6.78% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .31M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 112 Avg Trade Size (Sh.) (30 D): 70 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 188 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $.94M Avg Inst. Trade (90 D): $.9M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.32M Avg Closing Trade (30 D): $.84M Avg Closing Trade (90 D): $.84M Avg Closing Volume: 35.68K     News May 22, 2025 @ 10:00 AM Instil Bio and ImmuneOnco Announced the Phase 2 Tr... Source: N/A May 13, 2025 @ 11:00 AM Instil Bio Reports First Quarter 2025 Financial Re... Source: N/A Apr 1, 2025 @ 6:44 PM Tumor-infiltrating Lymphocyte (TIL) Therapies Glob... Source: Researchandmarkets.Com Jan 14, 2025 @ 12:00 PM Instil Bio Announces Clinical Progress in China fo... Source: N/A Oct 24, 2024 @ 9:13 AM Up Over 600% in 2024, Can Summit Therapeutics Stoc... Source: Cory Renauer Financials   TTM Q1 2025 Q4 2024 Basic EPS $-11.97 $-4.32 $-1.82 Diluted EPS $-11.97 $-4.32 $-1.82 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -78.03M $ -28.2M $ -11.9M Operating Income / Loss $ -80.15M $ -30.56M $ -11.82M Cost of Revenue $ $ $ Net Cash Flow $ 5.57M $ 5.69M $ 3.97M PE Ratio     Splits Dec 08, 2023:   1:20